The Milestone

Ideas & analysis

Articles

Reporting and analysis on the forces shaping biopharma.

President Reagan signing the Hatch-Waxman Act

Analysis ยท April 2026

Is There a Problem with Our Generic Drugs?

Everyone knows that drug costs are high, but can they also be too low? In a seeming paradox, concerned observers are saying yes. Despite growing evidence that patients face undue risk, changing the status quo remains difficult for politicians and healthcare leaders alike.

Stay informed

Sign Up for The Milestone